A detailed interdisciplinary program consisting of two phases is described which will prepare Jeffrey H. Periman, M.D. to be an independent basic scientist. In phase 1, he will be involved in rigorous didactic training and in experimental and theoretical studies simultaneously under close supervision of his co-sponsors. In phase 11, he will take on a more independent role in design and conduct of experiments and of theoretical analyses. Dr. Periman's progress will be evaluated by a committee of four senior scientists. Dr. Periman's training will center around a research project to define at the molecular and structural levels the binding site of the thyrotropin-releasing hormone receptor (TRH-R) using experimental and theoretical approaches in a complementary fashion. TRH is an important regulatory hormone for the anterior pituitary and an important neuromodulator in the CNS. The cloning of mouse pituitary TRH-R CDNA makes it possible to mutate the receptor and determine the effects of such changes on ligand binding. Combined with recent developments in macromolecular modeling of proteins and receptors, the TRH-R CDNA affords a special opportunity to define the binding site of the TRH-R and to initiate the construction of a three-dimensional (3-D) model of the TRH-R. Insights gained from this study should be applicable to other systems, particularly those involving small ligands. The working hypothesis is that the binding site of the TRH-R has several contact points on specific amino acid residues.
The specific aims are as follows: 1. To identify amino acid residues on the receptor that may be involved in TRH binding. To this end, existing structure-activity relationships, the Protein Data Bank, and theoretical methods will be used. 2. To determine which amino acids are involved in binding the TRH molecule. Site directed mutagenesis, binding assays, and TRH analogs will be used. 3. To construct a three-dimensional model of the TRH binding site in the TRH-R. To this end, the structure of TRH, the location of the amino acids involved in binding TRH, homology between TRH-R and bacteriorhodopsin, and helical interactions will be used to optimize the arrangement of the helices in space.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Physician Scientist Award (K11)
Project #
1K11DK002101-01
Application #
3086594
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1992-07-01
Project End
1997-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Varilek, G W; Yang, F; Lee, E Y et al. (2001) Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 131:2034-9
Colson, A O; Perlman, J H; Jinsi-Parimoo, A et al. (1998) A hydrophobic cluster between transmembrane helices 5 and 6 constrains the thyrotropin-releasing hormone receptor in an inactive conformation. Mol Pharmacol 54:968-78
Colson, A O; Perlman, J H; Smolyar, A et al. (1998) Static and dynamic roles of extracellular loops in G-protein-coupled receptors: a mechanism for sequential binding of thyrotropin-releasing hormone to its receptor. Biophys J 74:1087-100
Perlman, J H; Colson, A O; Jain, R et al. (1997) Role of the extracellular loops of the thyrotropin-releasing hormone receptor: evidence for an initial interaction with thyrotropin-releasing hormone. Biochemistry 36:15670-6
Perlman, J H; Colson, A O; Wang, W et al. (1997) Interactions between conserved residues in transmembrane helices 1, 2, and 7 of the thyrotropin-releasing hormone receptor. J Biol Chem 272:11937-42
Perlman, J H; Laakkonen, L J; Guarnieri, F et al. (1996) A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Experimental analysis and energy minimization of the complex between TRH and TRH receptor. Biochemistry 35:7643-50
Laakkonen, L; Li, W; Perlman, J H et al. (1996) Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone. Mol Pharmacol 49:1092-6
Laakkonen, L J; Guarnieri, F; Perlman, J H et al. (1996) A refined model of the thyrotropin-releasing hormone (TRH) receptor binding pocket. Novel mixed mode Monte Carlo/stochastic dynamics simulations of the complex between TRH and TRH receptor. Biochemistry 35:7651-63
Perlman, J H; Laakkonen, L; Osman, R et al. (1995) Distinct roles for arginines in transmembrane helices 6 and 7 of the thyrotropin-releasing hormone receptor. Mol Pharmacol 47:480-4
Perlman, J H; Thaw, C N; Laakkonen, L et al. (1994) Hydrogen bonding interaction of thyrotropin-releasing hormone (TRH) with transmembrane tyrosine 106 of the TRH receptor. J Biol Chem 269:1610-3

Showing the most recent 10 out of 12 publications